Payer National Outcomes Director — VIASKIN Peanut East

Description : Reporting to the Vice President, Corporate Account Management, the National Outcomes Director serves as a scientific expert and a key point of contact between DBV Technologies and external payer and population health decision-makers. As DBV prepares for the anticipated U.S. launch of the VIASKIN® Peanut Patch—a non-invasive epicutaneous immunotherapy (EPIT) for children with peanut allergy—this role is responsible for communicating evidence-based information on the product’s value proposition, advancing the understanding of health outcomes in pediatric food allergy, and fostering collaborative relationships with payers, integrated delivery networks, employers, and other organized customers. This is a field-based, scientific-exchange position central to ensuring that population health decision-makers have a clear, accurate, and timely understanding of the clinical and economic evidence supporting VIASKIN Peanut. Location : Remote Salary Range : $200-$240k Key Responsibilities : The following job duties are not all-inclusive, and additional responsibilities may be added to the role as needed. The duties and responsibilities listed are intended to provide a general overview of the position and may change over time based on the needs of the organization. Act as a subject matter expert on the health outcomes and economic impact of the VIASKIN Peanut Patch and the broader peanut allergy treatment landscape. Engage with national and regional payers, pharmacy benefit managers, integrated delivery networks, employers, and population health key opinion leaders to provide scientific, clinical, and economic information about VIASKIN Peanut. Communicate the value proposition of epicutaneous immunotherapy, including efficacy, safety, patch wear-time, and real-world relevance, to support informed coverage and formulary decisions. Conduct educational programs, scientific presentations, and value-evidence discussions to enhance understanding of product outcomes data among payer and population health audiences. Establish and maintain strong relationships with key external stakeholders, including medical and pharmacy directors, payer decision-makers, professional societies, and patient advocacy organizations in the food allergy community. Disseminate health outcomes data, real-world evidence, health economic models, and budget-impact analyses to support informed decision-making by payers and population health customers. Collaborate with internal cross-functional teams—including Market Access, Medical Affairs, Value & Access, Commercial, and Field Reimbursement—to align evidence strategies and ensure consistent, accurate messaging ahead of and through launch. Past history of designing outcomes based analytics using internal data sources or from external vendors. (e.g. Patient services data, Medical affairs, IQVIA, Optum Insights, Komodo) Provide training to internal teams on outcomes data and value evidence, ensuring a consistent and accurate understanding across the organization. Address unsolicited inquiries from payers and population health decision-makers regarding product information, clinical data, and outcomes research, in accordance with applicable regulations and company policy. Support investigator-initiated studies, real-world evidence generation, and other research initiatives that contribute to the understanding of health outcomes in pediatric peanut allergy. Contribute to the development of strategic plans for health outcomes research, value-evidence communication, and payer engagement in support of the VIASKIN Peanut launch. Collaborate with internal stakeholders to integrate health outcomes strategies into broader product launch, access, and commercialization plans. Ensure that all communication and interactions comply with regulatory requirements, legal guidance, and company policies. Qualifications : PharmD, M.D., or Ph.D. in a health sciences–related field required; Master’s in pharmacoepidemiology, epidemiology, or health economics preferred. Minimum of eight (8) years working in the pharmaceutical, biotechnology, or healthcare industry, with a minimum of five (5) years in a HEOR or payer-facing scientific function supporting product launches with U.S. Market Access teams. Experience spanning medical and scientific affairs, outcomes research, clinical practice, academic, or U.S. managed-markets settings. Therapeutic experience in allergy/immunology, pediatrics, and/or rare disease preferred; familiarity with the food allergy treatment landscape is a strong advantage. Strong understanding of health outcomes research, epidemiology, and health economics. · Demonstrated experience engaging national and regional payers, PBMs, IDNs, and other organized customers in a scientific or value-evidence capacity. Strong background and deep understanding of health economics, outcomes research methodologies, and evidence-generation techniques. Demonstrated expertise in economic modeling, budget-impact analysis, data analysis, and interpreting clinical and real-world data to generate meaningful insights. Stay updated on the latest industry trends, healthcare policies, and regulations impacting health economics and outcomes research, including those specific to pediatric and food allergy markets. Maintain a deep understanding of therapeutic areas of interest to the organization, including disease mechanisms, the treatment landscape, and relevant market dynamics. Excellent communication and presentation skills. Strong proficiency with relevant regulatory guidelines and requirements related to HEOR studies and payer scientific exchange. Understanding of compliance and ethical considerations in conducting research and engaging with payer decision-makers. Possess excellent written and verbal communication skills to effectively convey complex HEOR concepts to both technical and non-technical stakeholders. Ability to engage and build strong relationships with external stakeholders, including thought leaders and academic experts in the field of HEOR. Behavioral skills : Ability to collaborate effectively with cross-functional teams. Demonstrated ability to effectively manage multiple projects, prioritize tasks, meet deadlines, and adapt to changing priorities. Proficient in resource allocation, budget management, and project planning to ensure successful execution of HEOR initiatives. Comfort operating in an ambiguous, fast paced, pre-commercial environment Curiosity – demonstrated desire to learn, explore, and understand new things. Courage – ability to confront fear, uncertainty, and challenges with confidence and resolve. · Collaboration -working with others to achieve a common goal. Credibility – builds trust, is reliable, acts with ethics and integrity. Ability to articulate clearly and conduct verbal presentations with large and small audiences. #J-18808-Ljbffr DBV Technologies